G49108TO

Summary
GlyTouCan ID
G49108TO
IUPAC Condensed
GlcNAc(b1-
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
The Human Metabolome Database
3D Structures
GLYCAM
DGlcpNAcb1-OH
GlycoShape
G49108TO
Displaying 1 entry
Archetype α β
G14843DJ
G68544GH
G49108TO
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying entries 1 - 5 of 10 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
B4GALT5 (not applicable)
G49108TO
[beta]-S-pNP
G00055MO
[beta]-S-pNP
B3GALT2 UDP-Gal
G49108TO
Lemieux
G00056MO
Lemieux
B4GALT2 UDP-Gal
G49108TO
Benzyl-[beta]
G00055MO
Benzyl-[beta]
B4GALT1 UDP-Gal
G49108TO
R
G00055MO
R
B3GALT5 UDP-Gal
G49108TO
R
G00056MO
R
Displaying entries 11 - 15 of 25 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
B4GALT4 UDP-Gal
G49108TO
[beta]-1-p-Nitrophenyl
G00055MO
[beta]-1-p-Nitrophenyl
B4GALT2 UDP-Gal
G49108TO
Benzyl-[beta]
G00055MO
Benzyl-[beta]
B4GALT1 UDP-Gal
G49108TO
R
G00055MO
R
B4GALT3 UDP-Gal
G49108TO
p-Nitrophenyl-[beta]
G00055MO
p-Nitrophenyl-[beta]
B4GALT5 UDP-Gal
G49108TO
G00055MO
Displaying entries 1 - 5 of 24 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Reference
ST6GAL2 CMP-Neu5Ac
G49108TO
para-nitrophenol
ST6GALNAC2 CMP-Neu5Ac
G49108TO
benzyl
ST6GAL1 CMP-Neu5Ac
G49108TO
para-nitrophenol
CHST7 PAPS
G49108TO
-O-CH3
CHST3 PAPS
G49108TO
-O-CH3
KEGG BRITE Database
KEGG ID
Enzyme
GlycoEpitope
Epitope ID
EP0004
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
LIN
1:1d(2+1)2n
WURCS
WURCS=2.0/1,1,0/[a2122h-1b_1-5_2*NCC/3=O]/1/
Literature
Displaying entries 1381 - 1390 of 10696 in total
PubMed ID Title First Author Publication Date Source
33981040 Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition Yu J 2021 May 12
  • PubChem
33820835 The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates Jones BE 2021 May 12
  • PubChem
33976149 Single-component multilayered self-assembling nanoparticles presenting rationally designed glycoprotein trimers as Ebola virus vaccines He L 2021 May 11
  • PubChem
33741634 Considerations Regarding Activity Determinants of Fungal Polyphenol Oxidases Based on Mutational and Structural Studies Nikolaivits E 2021 May 11
  • PubChem
33976198 A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes Guo Y 2021 May 11
  • PubChem
33932326 Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2 Zhou X 2021 May 11
  • PubChem
33692208 A Vulnerable, Membrane-Proximal Site in Human Respiratory Syncytial Virus F Revealed by a Prefusion-Specific Single-Domain Antibody Rossey I 2021 May 10
  • PubChem
33692215 Cryo-electron Microscopy Structure of S-Trimer, a Subunit Vaccine Candidate for COVID-19 Ma J 2021 May 10
  • PubChem
33934433 Plasmodium chitinases: revisiting a target of transmission‐blockade against malaria Viswanath VK 2021 May 08
  • PubChem
33961028 CD1a selectively captures endogenous cellular lipids that broadly block T cell response Cotton RN 2021 May 07
  • PubChem

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.3.0

Last updated: August 4, 2025